Safety Study to Determine the Optimal Human Challenge Dose for Norovirus GII.4 CIN-3 Batch No.: 01-16C3
Condition: Gastroenteritis Norovirus Intervention: Biological: Norovirus GII.4 Challenge Pool Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Gastroenterology | Infectious Diseases | Norovirus | Research | Study